COVID-19 has accelerated data-driven innovation across the globe, with artificial intelligence and data science at the forefront of addressing human disease and health. London & Partners and MedCity have launched a report on London as an Innovation Hub for Health and Life Sciences – through the application of Data and AI with practical advice for innovators to navigate the UK’s healthcare system, opportunities to collaborate, and case studies from companies already scaling here.
UCLPartners’ expertise in collaborating with industry and identifying health system needs for innovation and technology has been highlighted in the report. Innovators come to UCLPartners for support in navigating the complex health landscape and guidance on building their evidence base to increase their chances of adoption in the UK.
As part of London’s diverse and data-rich environment, there is a focus on DATA-CAN, which is hosted by UCLPartners, for its work in making high-quality health data more accessible for research. DATA-CAN supports life sciences companies by identifying research-ready cancer datasets, making introductions to appropriate data controllers and providing expert advisory services.
The convergence of London’s world-leading life sciences cluster and its AI capabilities are a testbed environment for companies to grow, scale and collaborate. With case studies of successful companies, cluster knowledge, market access advice, and information on London’s data-rich environment, the report showcases the support and resources available to allow innovators to scale.
Read the full report here and find out more about life sciences support from London & Partners and MedCity